{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T23:59:38Z","timestamp":1792886378235,"version":"4.5.0"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"42","license":[{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10,18]]},"abstract":"<jats:p>In patients with mucopolysaccharidosis (MPS), the accumulation of glycosaminoglycans leads to various complications, including spinal cord compression (SCC). Although SCC is a well-known complication in MPS, data comparing its clinical features across different MPS types remain limited. This study aimed to investigate the timing, location, and underlying causes of SCC in MPS, as well as to compare the risk and clinical characteristics by MPS type. We conducted a retrospective cohort study, reviewing the medical records of 183 patients with all types of MPS who were followed at Samsung Medical Center from January 1995 to March 2024. The distribution of patients diagnosed with SCC by MPS type was 33.3% for type I, 10.5% for type II, 55.0% for type IV, and 100% for type VI. The median age at SCC diagnosis was 16.3 years. Compared to type II, the risk of SCC was higher for type I (2.4 times, 95% confidence interval [CI]: 0.9\u20136.2), type IV (3.5 times; 95% CI: 1.5\u20138.1), and type VI (4.5 times, 95% CI: 1.2\u201316.4). Enzyme replacement therapy did not reduce the risk of SCC (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.70). Moreover, SCC most frequently occurred at the C0 to C4 and T11 to L2 spinal levels. In the cervical spine, ligament thickening, and skeletal deformities were the predominant causes, whereas in the thoracolumbar spine, kyphoscoliosis and intervertebral disc issues were the main contributors. Although there was no significant difference in the location of SCC (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.99), the underlying causes varied significantly by MPS type (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001). SCC is a common complication in MPS, but its risk and pathophysiology vary by MPS type. Therefore, an individualized approach is needed for early detection and appropriate intervention.<\/jats:p>","DOI":"10.1097\/md.0000000000040113","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T18:02:06Z","timestamp":1730138526000},"page":"e40113","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Risk and clinical characteristics of spinal cord compression across different mucopolysaccharidosis types: A retrospective cohort study"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-5875-738X","authenticated-orcid":false,"given":"Insung","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3933-6586","authenticated-orcid":false,"given":"Juyoung","family":"Sung","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9181-7758","authenticated-orcid":false,"given":"Yoon Ji","family":"Ahn","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8114-844X","authenticated-orcid":false,"given":"Minji","family":"Im","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5102-0536","authenticated-orcid":false,"given":"Min-Ji","family":"Kim","sequence":"additional","affiliation":[{"name":"Biomedical Statistics Center, Research Institute for Future Medicine, Samsung Medical Center, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2412-9437","authenticated-orcid":false,"given":"Se-Jun","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2913-059X","authenticated-orcid":false,"given":"Sung Yoon","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ymgme.2018.01.003","article-title":"Clinical presentation and diagnosis of mucopolysaccharidoses.","volume":"125","author":"Stapleton","year":"2018","journal-title":"Mol Genet Metab"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.3390\/cells9081838","article-title":"Mucopolysaccharidosis type I: a review of the natural history and molecular pathology.","volume":"9","author":"Hampe","year":"2020","journal-title":"Cells"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.3390\/ijms21041258","article-title":"Mucopolysaccharidosis type II: one hundred years of research, diagnosis, and treatment.","volume":"21","author":"D\u2019Avanzo","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"13456","DOI":"10.3390\/ijms222413456","article-title":"Mucopolysaccharidosis type VI, an updated overview of the disease.","volume":"22","author":"D\u2019Avanzo","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1750-1172-9-21","article-title":"Natural history and clinical assessment of Taiwanese patients with mucopolysaccharidosis IVA.","volume":"9","author":"Lin","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.3390\/ijms21072515","article-title":"Pathogenesis of Mucopolysaccharidoses, an Update.","volume":"21","author":"Fecarotta","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jpeds.2015.11.079","article-title":"A prospective natural history study of mucopolysaccharidosis type IIIA.","volume":"170","author":"Shapiro","year":"2016","journal-title":"J Pediatr"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"100874","DOI":"10.1016\/j.spen.2021.100874","article-title":"Update in the mucopolysaccharidoses.","volume":"37","author":"McBride","year":"2021","journal-title":"Semin Pediatr Neurol"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"e226","DOI":"10.1016\/j.bbmt.2019.02.012","article-title":"Hematopoietic stem cell transplantation for mucopolysaccharidoses: past, present, and future.","volume":"25","author":"Taylor","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s10545-011-9317-5","article-title":"Brain and spine MRI features of hunter disease: frequency, natural evolution and response to therapy.","volume":"34","author":"Manara","year":"2011","journal-title":"J Inherit Metab Dis"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s10545-011-9309-5","article-title":"The craniocervical junction following successful haematopoietic stem cell transplantation for mucopolysaccharidosis type I H (Hurler syndrome).","volume":"34","author":"Miebach","year":"2011","journal-title":"J Inherit Metab Dis"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ymgme.2012.07.018","article-title":"A multinational, multidisciplinary consensus for the diagnosis and management of spinal cord compression among patients with mucopolysaccharidosis VI.","volume":"107","author":"Solanki","year":"2012","journal-title":"Mol Genet Metab"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1007\/s00586-022-07168-0","article-title":"Spinal cord compression in patients with mucopolysaccharidosis.","volume":"31","author":"Pantel","year":"2022","journal-title":"Eur Spine J"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s10545-013-9586-2","article-title":"Spinal involvement in mucopolysaccharidosis IVA (morquio-brailsford or morquio a syndrome): presentation, diagnosis and management.","volume":"36","author":"Solanki","year":"2013","journal-title":"J Inherit Metab Dis"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ymgme.2016.06.002","article-title":"Pathogenesis and treatment of spine disease in the mucopolysaccharidoses.","volume":"118","author":"Peck","year":"2016","journal-title":"Mol Genet Metab"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.3390\/ijms21031171","article-title":"Surgical management of spinal disorders in people with mucopolysaccharidoses.","volume":"21","author":"Terai","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1517\/21678707.2015.1086640","article-title":"Enzyme replacement therapy for treating mucopolysaccharidosis type IVA (morquio a syndrome): effect and limitations.","volume":"3","author":"Tomatsu","year":"2015","journal-title":"Expert Opin Orphan Drugs"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13052-018-0562-1","article-title":"Enzyme replacement therapy: efficacy and limitations.","volume":"44","author":"Concolino","year":"2018","journal-title":"Ital J Pediatr"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.3390\/ijms21041517","article-title":"Mucopolysaccharidosis IVA: diagnosis, treatment, and management.","volume":"21","author":"Sawamoto","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10545-011-9304-x","article-title":"Orthopaedic management of Hurler\u2019s disease after hematopoietic stem cell transplantation: a systematic review.","volume":"34","author":"van der Linden","year":"2011","journal-title":"J Inherit Metab Dis"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ymgme.2015.07.005","article-title":"Safety of laronidase delivered into the spinal canal for treatment of cervical stenosis in mucopolysaccharidosis I.","volume":"116","author":"Dickson","year":"2015","journal-title":"Mol Genet Metab"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00264-018-4143-0","article-title":"Spine challenges in mucopolysaccharidosis.","volume":"43","author":"Crostelli","year":"2019","journal-title":"Int Orthop"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/BPO.0b013e31821f5ee9","article-title":"Musculoskeletal manifestations of Sanfilippo syndrome (mucopolysaccharidosis type III).","volume":"31","author":"White","year":"2011","journal-title":"J Pediatr Orthop"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00381-014-2578-1","article-title":"Spinal involvement in mucopolysaccharidoses: a review.","volume":"31","author":"Leone","year":"2015","journal-title":"Childs Nerv Syst"},{"key":"R25-20250503","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1542\/peds.2008-0416","article-title":"Mucopolysaccharidosis I: management and treatment guidelines.","volume":"123","author":"Muenzer","year":"2009","journal-title":"Pediatrics"},{"key":"R26-20250503","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13023-019-1074-9","article-title":"Recommendations for the management of MPS IVA: systematic evidence- and consensus-based guidance.","volume":"14","author":"Akyol","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"R27-20250503","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13023-019-1080-y","article-title":"Recommendations for the management of MPS VI: systematic evidence- and consensus-based guidance.","volume":"14","author":"Akyol","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"R28-20250503","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000371658","article-title":"Cervical spine MRI findings in patients with mucopolysaccharidosis type II.","volume":"50","author":"\u017buber","year":"2015","journal-title":"Pediatr Neurosurg"},{"key":"R29-20250503","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1750-1172-6-72","article-title":"Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease.","volume":"6","author":"Scarpa","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"R30-20250503","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/s13023-020-01598-z","article-title":"Survival and diagnostic age of 175 Taiwanese patients with mucopolysaccharidoses (1985-2019).","volume":"15","author":"Lin","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"R31-20250503","first-page":"65","article-title":"Development of a scoring system to evaluate the severity of craniocervical spinal cord compression in patients with mucopolysaccharidosis IVA (morquio a syndrome).","volume":"11","author":"M\u00f6llmann","year":"2013","journal-title":"JIMD Rep"},{"key":"R32-20250503","doi-asserted-by":"crossref","first-page":"1","DOI":"10.17305\/bjbms.2017.2201","article-title":"Anesthesia for patients with mucopolysaccharidoses: comprehensive review of the literature with emphasis on airway management.","volume":"18","author":"Clark","year":"2018","journal-title":"Bosn J Basic Med Sci"},{"issue":"Suppl 2","key":"R33-20250503","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13052-018-0554-1","article-title":"Anesthesiological risks in mucopolysaccharidoses.","volume":"44","author":"Moretto","year":"2018","journal-title":"Ital J Pediatr"},{"key":"R34-20250503","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s10545-017-0075-x","article-title":"Survival in idursulfase-treated and untreated patients with mucopolysaccharidosis type II: data from the hunter outcome survey (HOS).","volume":"40","author":"Burton","year":"2017","journal-title":"J Inherit Metab Dis"},{"key":"R35-20250503","doi-asserted-by":"crossref","first-page":"232640981875580","DOI":"10.1177\/2326409818755800","article-title":"Long-term galsulfase treatment associated with improved survival of patients with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): 15-year follow-up from the survey study.","volume":"6","author":"Quartel","year":"2018","journal-title":"J Inborn Errors Metab Screen"},{"key":"R36-20250503","first-page":"59","article-title":"Mortality in patients with morquio syndrome a.","volume":"15","author":"Lavery","year":"2015","journal-title":"JIMD Rep"},{"key":"R37-20250503","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3390\/ijms21020400","article-title":"Novel enzyme replacement therapies for neuropathic mucopolysaccharidoses.","volume":"21","author":"Sato","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R38-20250503","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3390\/diagnostics11020273","article-title":"Epidemiology of mucopolysaccharidoses update.","volume":"11","author":"\u00c7elik","year":"2021","journal-title":"Diagnostics (Basel)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040113","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:17:32Z","timestamp":1746317852000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,18]]},"references-count":38,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000040113","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,18]]}}}